Lotus Bio-Technology Development Corp. (LBTD)

USD 0.01

(0.0%)

EBITDA Summary of Lotus Bio-Technology Development Corp.

Lotus Bio-Technology Development Corp.'s latest annual EBITDA in 2023 was - USD , down 0.0% from previous year.
Lotus Bio-Technology Development Corp.'s latest quarterly EBITDA in 2023 FY was N/A , down 0.0% from previous quarter.
Lotus Bio-Technology Development Corp. reported an annual EBITDA of - USD in 2022, down 0.0% from previous year.
Lotus Bio-Technology Development Corp. reported an annual EBITDA of - USD in 2021, down 0.0% from previous year.
Lotus Bio-Technology Development Corp. reported a quarterly EBITDA of N/A for 2022 FY, down 0.0% from previous quarter.
Lotus Bio-Technology Development Corp. reported a quarterly EBITDA of N/A for 2021 FY, down 0.0% from previous quarter.

Annual EBITDA Chart of Lotus Bio-Technology Development Corp. (2023 - 2011)

Historical Annual EBITDA of Lotus Bio-Technology Development Corp. (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	- USD	0.0%
2022	- USD	0.0%
2021	- USD	0.0%
2020	- USD	0.0%
2019	- USD	0.0%
2017	-19.55 Thousand USD	0.0%
2016	-780.01 Thousand USD	-4065.85%
2015	-18.72 Thousand USD	55.04%
2014	-41.64 Thousand USD	32.92%
2013	-62.07 Thousand USD	-1346.82%
2012	4979.00 USD	132.02%
2011	-15.55 Thousand USD	0.0%

Year	EBITDA	EBITDA Growth
2023 FY	- USD	0.0%
2022 FY	- USD	0.0%
2021 FY	- USD	0.0%
2020 FY	- USD	0.0%
2019 FY	- USD	0.0%
2018 Q3	-11.34 Thousand USD	25.7%
2018 Q2	-15.27 Thousand USD	-16867.78%
2018 Q1	-90.00 USD	99.99%
2017 FY	- USD	0.0%
2017 Q3	-11.89 Thousand USD	-282.29%
2017 Q4	-758.99 Thousand USD	-6281.9%
2017 Q2	-3111.00 USD	-222.72%
2017 Q1	-964.00 USD	99.87%
2016 Q4	-768.4 Thousand USD	-11670.91%
2016 FY	- USD	-4065.85%
2016 Q2	-4019.00 USD	-86.67%
2016 Q1	-2153.00 USD	-108.42%
2016 Q3	-6528.00 USD	-62.43%
2015 Q3	-12.96 Thousand USD	28.52%
2015 FY	- USD	55.04%
2015 Q1	-29.94 Thousand USD	-0.21%
2015 Q2	-18.13 Thousand USD	39.45%
2015 Q4	25.58 Thousand USD	297.39%
2014 Q4	-29.87 Thousand USD	-653.35%
2014 Q2	-2249.00 USD	59.48%
2014 Q1	-5550.00 USD	76.96%
2014 FY	- USD	32.92%
2014 Q3	-3966.00 USD	-76.35%
2013 Q3	-25.75 Thousand USD	-1264.3%
2013 Q4	-24.08 Thousand USD	6.49%
2013 FY	- USD	-1346.82%
2013 Q2	-1888.00 USD	81.65%
2013 Q1	-10.28 Thousand USD	-221.68%
2012 Q3	-200.00 USD	0.0%
2012 Q2	-200.00 USD	93.5%
2012 Q1	-3075.00 USD	0.0%
2012 Q4	8454.00 USD	4327.0%
2012 FY	- USD	132.02%
2011 FY	- USD	0.0%

Peer EBITDA Comparison of Lotus Bio-Technology Development Corp.

Name	EBITDA	EBITDA Difference
Allied Energy Corporation	-279.93 Thousand USD	100.0%
Earth Alive Clean Technologies Inc.	-4.04 Million USD	100.0%
Igene Biotechnology, Inc.	-851.28 Thousand USD	100.0%
MagIndustries Corp.	-27.23 Million USD	100.0%
Itafos Inc.	53.75 Million USD	100.0%
Potash America, Inc.	-317.38 Thousand USD	100.0%
Yara International ASA	1.45 Billion USD	100.0%
Yara International ASA	1.51 Billion USD	100.0%